|
Name |
5-Hydroxy-4-octanone
|
Molecular Formula | C8H16O2 | |
IUPAC Name* |
5-hydroxyoctan-4-one
|
|
SMILES |
CCCC(C(=O)CCC)O
|
|
InChI |
InChI=1S/C8H16O2/c1-3-5-7(9)8(10)6-4-2/h7,9H,3-6H2,1-2H3
|
|
InChIKey |
BVEYJWQCMOVMAR-UHFFFAOYSA-N
|
|
Synonyms |
5-Hydroxyoctan-4-one; 5-Hydroxy-4-octanone; Butyroin; 496-77-5; 4-Octanone, 5-hydroxy-; 5-Octanol-4-one; Octan-4-ol-5-one; FEMA No. 2587; WG070EDJ4X; NSC-1479; 5-hydroxy-octan-4-one; UNII-WG070EDJ4X; NSC 1479; EINECS 207-830-4; 4-hydroxy-5-octanone; AI3-05612; BUTYROIN [MI]; SCHEMBL26945; (+/-)-BUTYROIN; (+/-)-5-Hydroxy-4-octanone; DTXSID60862040; NSC1479; CHEBI:179933; MFCD00021928; 5-HYDROXY-4-OCTANONE [FHFI]; AKOS006227777; DS-16801; B0971; FT-0623349; D88723; A827795; Q27292617
|
|
CAS | 496-77-5 | |
PubChem CID | 219794 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 144.21 | ALogp: | 1.4 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 37.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 10 | QED Weighted: | 0.641 |
Caco-2 Permeability: | -4.255 | MDCK Permeability: | 0.00003070 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.187 |
Human Intestinal Absorption (HIA): | 0.011 | 20% Bioavailability (F20%): | 0.231 |
30% Bioavailability (F30%): | 0.007 |
Blood-Brain-Barrier Penetration (BBB): | 0.758 | Plasma Protein Binding (PPB): | 52.80% |
Volume Distribution (VD): | 0.714 | Fu: | 52.83% |
CYP1A2-inhibitor: | 0.09 | CYP1A2-substrate: | 0.871 |
CYP2C19-inhibitor: | 0.032 | CYP2C19-substrate: | 0.757 |
CYP2C9-inhibitor: | 0.012 | CYP2C9-substrate: | 0.895 |
CYP2D6-inhibitor: | 0.006 | CYP2D6-substrate: | 0.588 |
CYP3A4-inhibitor: | 0.006 | CYP3A4-substrate: | 0.132 |
Clearance (CL): | 8.63 | Half-life (T1/2): | 0.913 |
hERG Blockers: | 0.016 | Human Hepatotoxicity (H-HT): | 0.184 |
Drug-inuced Liver Injury (DILI): | 0.123 | AMES Toxicity: | 0.082 |
Rat Oral Acute Toxicity: | 0.105 | Maximum Recommended Daily Dose: | 0.029 |
Skin Sensitization: | 0.1 | Carcinogencity: | 0.032 |
Eye Corrosion: | 0.252 | Eye Irritation: | 0.947 |
Respiratory Toxicity: | 0.053 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000889 | 0.421 | D0Y3KG | 0.486 | ||||
ENC000306 | 0.405 | D03LGY | 0.274 | ||||
ENC000738 | 0.395 | D07CNL | 0.242 | ||||
ENC000245 | 0.395 | D0G8SQ | 0.233 | ||||
ENC000890 | 0.385 | D07SJT | 0.231 | ||||
ENC000226 | 0.382 | D00WUF | 0.227 | ||||
ENC000232 | 0.382 | D0R3QY | 0.225 | ||||
ENC000231 | 0.375 | D01OPV | 0.225 | ||||
ENC000018 | 0.367 | D0L7FM | 0.222 | ||||
ENC000685 | 0.361 | D0CT4D | 0.222 |